1/14
07:51 am
anro
Alto Neuroscience Strengthens Intellectual Property Portfolio with Issuance of New Method-of-Treatment Patent for ALTO-207 in Depression [Yahoo! Finance]
Medium
Report
Alto Neuroscience Strengthens Intellectual Property Portfolio with Issuance of New Method-of-Treatment Patent for ALTO-207 in Depression [Yahoo! Finance]
1/14
07:27 am
anro
Alto Neuroscience Strengthens Intellectual Property Portfolio with Issuance of New Method-of-Treatment Patent for ALTO-207 in Depression
Low
Report
Alto Neuroscience Strengthens Intellectual Property Portfolio with Issuance of New Method-of-Treatment Patent for ALTO-207 in Depression
1/14
03:53 am
anro
Alto Neuroscience Presents New Data at the 64th Annual Meeting of the American College of Neuropsychopharmacology [Yahoo! Finance]
Low
Report
Alto Neuroscience Presents New Data at the 64th Annual Meeting of the American College of Neuropsychopharmacology [Yahoo! Finance]
1/13
08:00 am
anro
Alto Neuroscience Presents New Data at the 64th Annual Meeting of the American College of Neuropsychopharmacology
Medium
Report
Alto Neuroscience Presents New Data at the 64th Annual Meeting of the American College of Neuropsychopharmacology
1/5
08:33 am
anro
Alto Neuroscience (NYSE:ANRO) had its price target raised by analysts at Chardan Capital from $15.00 to $30.00. They now have a "buy" rating on the stock.
Low
Report
Alto Neuroscience (NYSE:ANRO) had its price target raised by analysts at Chardan Capital from $15.00 to $30.00. They now have a "buy" rating on the stock.
12/26
08:57 am
anro
Alto Neuroscience, Inc. (NYSE:ANRO) is definitely on the radar of institutional investors who own 33% of the company [Yahoo! Finance]
Medium
Report
Alto Neuroscience, Inc. (NYSE:ANRO) is definitely on the radar of institutional investors who own 33% of the company [Yahoo! Finance]
12/3
04:05 pm
anro
Alto Neuroscience Announces New Employee Inducement Grants Under NYSE Rule 303A.08
Low
Report
Alto Neuroscience Announces New Employee Inducement Grants Under NYSE Rule 303A.08
12/1
05:42 pm
anro
Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Alto Neuroscience, Inc. (ANRO), Atkore Inc. (ATKR), Dow Inc. (DOW), and Fly-E Group, Inc. (FLYE)
Low
Report
Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Alto Neuroscience, Inc. (ANRO), Atkore Inc. (ATKR), Dow Inc. (DOW), and Fly-E Group, Inc. (FLYE)
11/21
05:30 am
anro
Alto Neuroscience (NYSE:ANRO) was upgraded by analysts at Chardan Capital to a "strong-buy" rating.
Medium
Report
Alto Neuroscience (NYSE:ANRO) was upgraded by analysts at Chardan Capital to a "strong-buy" rating.
11/17
08:06 am
anro
Alto Neuroscience (NYSE:ANRO) is now covered by analysts at BTIG Research. They set a "buy" rating and a $27.00 price target on the stock.
High
Report
Alto Neuroscience (NYSE:ANRO) is now covered by analysts at BTIG Research. They set a "buy" rating and a $27.00 price target on the stock.
11/15
01:42 am
anro
Alto Neuroscience (NYSE:ANRO) was upgraded by analysts at
Wall Street Ze
High
Report
Alto Neuroscience (NYSE:ANRO) was upgraded by analysts at
Wall Street Ze
11/13
08:11 am
anro
Alto Neuroscience (NYSE:ANRO) had its price target raised by analysts at Robert W. Baird from $16.00 to $22.00. They now have an "outperform" rating on the stock.
High
Report
Alto Neuroscience (NYSE:ANRO) had its price target raised by analysts at Robert W. Baird from $16.00 to $22.00. They now have an "outperform" rating on the stock.
11/12
02:53 pm
anro
Alto Neuroscience (NYSE:ANRO) had its price target raised by analysts at Jefferies Financial Group Inc. from $15.00 to $25.00. They now have a "buy" rating on the stock.
Low
Report
Alto Neuroscience (NYSE:ANRO) had its price target raised by analysts at Jefferies Financial Group Inc. from $15.00 to $25.00. They now have a "buy" rating on the stock.
11/12
09:57 am
anro
Alto Neuroscience GAAP EPS of -$0.52 [Seeking Alpha]
Low
Report
Alto Neuroscience GAAP EPS of -$0.52 [Seeking Alpha]
11/12
07:57 am
anro
Alto Neuroscience Reports Third Quarter 2025 Financial Results and Recent Business Highlights
Low
Report
Alto Neuroscience Reports Third Quarter 2025 Financial Results and Recent Business Highlights
11/11
09:21 am
anro
NYSE Content Advisory: Pre-Market Update + Government Shutdown Nears End After 42 Days [Yahoo! Finance]
Medium
Report
NYSE Content Advisory: Pre-Market Update + Government Shutdown Nears End After 42 Days [Yahoo! Finance]
10/28
07:34 am
anro
Alto Neuroscience to Participate in Upcoming Investor Conferences
Medium
Report
Alto Neuroscience to Participate in Upcoming Investor Conferences
10/24
08:06 am
anro
Alto Neuroscience (NYSE:ANRO) had its price target raised by analysts at HC Wainwright from $10.00 to $50.00. They now have a "buy" rating on the stock.
Medium
Report
Alto Neuroscience (NYSE:ANRO) had its price target raised by analysts at HC Wainwright from $10.00 to $50.00. They now have a "buy" rating on the stock.